II-Alpha Premium

Latest Articles

Chris Hansen (The Seattle Times / Erika Shultz)

Valiant Bets on Big Changes in the Global Economy

Stephen Taub March 14, 2023

Alex Kraus/Bloomberg

SPAC Bankruptcies Rock Hedge Funds

Stephen Taub March 13, 2023

Victor J. Blue/Bloomberg

Software Stocks Propel Cadian

Stephen Taub March 10, 2023

Victor J. Blue/Bloomberg

Haidar Jupiter Takes a 5 Percent Hit

Stephen Taub March 9, 2023

Diverse uses for ETFs

ETFs: An Indispensable Tool for Rising Volatility

Sponsored by iShares March 9, 2023

Illustration by II

AQR Leads Multistrats in February

Stephen Taub March 8, 2023

Left to right: David Tepper, Izzy Englander, Ken Griffin, Jim Simons, Steve Cohen (Bloomberg and courtesy photos)

The Complete Rich List: The 22nd Annual Ranking of the Highest-Earning Hedge Fund Managers

Stephen Taub March 7, 2023

Dan Loeb (David Paul Morris/Bloomberg)

Third Point Posts a Sizable Loss

Stephen Taub March 6, 2023

Nir Bar Dea (Courtesy photo)

Bridgewater to Restrict Access to Flagship Fund

Stephen Taub March 3, 2023

Kholood Eid/Bloomberg

Glenview Takes a Loss

Stephen Taub March 2, 2023

David Einhorn (Andrew Harrer/Bloomberg)

Greenlight Ekes Out a Small Gain in February

Stephen Taub March 1, 2023

(Victor J. Blue/Bloomberg)

Icahn’s Private Hedge Fund Lost Money in 2022

Stephen Taub February 28, 2023

Nicky Loh/Bloomberg

There’s New Hope for the IPO Market

Stephen Taub February 27, 2023

Dan Gibson (Courtesy Photo)

Can a Tiger Change Its Stripes? Sylebra Capital Thinks So.

Stephen Taub February 24, 2023

iShares

A Rising Tide in Thematic ETFs

Sponsored by iShares February 23, 2023

David Paul Morris, Bloomberg

Hedge Funds Are Still Sticking to the Same Stocks

Stephen Taub February 23, 2023

Ken Tropin (Bloomberg / Jacob Kelper)

Why Macro Investor Ken Tropin Is Cautiously Optimistic

Stephen Taub February 22, 2023

Toru Hanai/Bloomberg

Casdin Leads a Biopharma Surge

Stephen Taub February 21, 2023

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.03 build:2025-12-12 Login